E. Haupt

Most-cited papers

1. Prealbumin serum concentrations as a useful tool in the assessment of malnutrition in hospitalized patients.

   G. Devoto, F. Gallo, C. Marchello, O. Racchi +4 more

   2006Clinical Chemistry198 citations Open access

   Semantic Scholar

   Save

2. Benfotiamine in the treatment of diabetic polyneuropathy--a three-week randomized, controlled pilot study (BEDIP study).

   E. Haupt, H. Ledermann, W. Köpcke

   2005International journal of clinical pharmacology and therapeutics166 citations

   Semantic Scholar

   Save

3. Oral antidiabetic combination therapy with sulphonylureas and metformin.

   E. Haupt, B. Knick, T. Koschinsky, H. Liebermeister +2 more

   1991Diabete & metabolisme112 citations

   Semantic Scholar

   Save

4. Use of botulinum toxin in the treatment of one hundred patients with facial dyskinesias.

   J. Mauriello, H. Coniaris, E. Haupt

   1987Ophthalmology (Rochester, Minn.)59 citations

   Semantic Scholar

   Save

5. [Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides (author's transl)].

   E. Haupt, F. Laube, H. Loy, K. Schöffling

   1977Medizinische Klinik30 citations

   Semantic Scholar

   Save

6. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.

   C. Rosak, E. Haupt, T. Walter, J. Werner

   2002Diabetes, Nutrition and Metabolism. Clinical and Experimental25 citations

   Semantic Scholar

   Save

7. The KID Study VI: diabetic complications and associated diseases in younger type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptide.

   E. Haupt, A. Benecke, A. Haupt, R. Herrmann +2 more

   2009Experimental and clinical endocrinology & diabetes19 citations

   Semantic Scholar

   Save

8. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride, and glisoxepide

   E. Haupt, W. Köberich, J. Beyer, K. Schöffling

   1971Diabetologia16 citations Open access

   Semantic Scholar

   Save

9. The KID Study V: the natural history of type 2 diabetes in younger patients still practising a profession. Heterogeneity of basal and reactive C-peptide levels in relation to BMI, duration of disease, age and HbA1.

   E. Haupt, A. Haupt, R. Herrmann, A. Benecke-Timp +2 more

   2009Experimental and clinical endocrinology & diabetes15 citations

   Semantic Scholar

   Save

10. [Mexiletine in treatment of painful diabetic neuropathy].

    H. Stracke, U. Meyer, H. Schumacher, U. Armbrecht +6 more

    1994Medizinische Klinik14 citations

    Semantic Scholar

    Save

11. Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide

    E. Haupt, W. Köberich, J. Beyer, K. Schöffling

    1971Diabetologia12 citations Open access

    Semantic Scholar

    Save

12. The KID Study II: Socioeconomic baseline characteristics, psycho-social strain, standard of current medical care and education of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation

    E. Haupt, R. Herrmann, A. Benecke-Timp, H. Vogel +2 more

    2009Experimental and clinical endocrinology & diabetes5 citations

    Semantic Scholar

    Save

13. The KID Study III: Impact of inpatient rehabilitation on the metabolic control of type I and type II diabetics — a one-year follow-up

    E. Haupt, R. Herrmann, A. Benecke-Timp, H. Vogel +3 more

    2009Experimental and clinical endocrinology & diabetes4 citations

    Semantic Scholar

    Save

14. The KID Study I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation

    E. Haupt, R. Herrmann, A. Benecke-Timp, H. Vogel +3 more

    2009Experimental and clinical endocrinology & diabetes4 citations

    Semantic Scholar

    Save

15. Different Amounts of Insulin Secretion Following an Equal Total Decrease of Blood Glucose as an Indication of Possible Extrapancreatic Activities of Different Sulfonylurea Drugs

    J. Beyer, E. Haupt, U. Cordes, J. Kutschera +1 more

    1973Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme4 citations

    Semantic Scholar

    Save

16. [Interactions of non-steroidal antirheumatic drugs with oral antidiabetic agents: acemetacin--glibenclamide].

    E. Haupt, F. Hoppe, H. Rechziegler, P. Zündorf

    1987Zeitschrift für Rheumatologie (Print)3 citations

    Semantic Scholar

    Save

17. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].

    E. Haupt, J. Beyer, K. Schöffling

    1974Deutsche Medizinische Wochenschrift3 citations

    Semantic Scholar

    Save

18. Seriate prealbumin and C-reactive protein measurements in monitoring nutritional intervention in hospitalized patients: a prospective observational study

    F. Gallo, E. Haupt, G. Devoto, C. Marchello +5 more

    20112 citations

    Semantic Scholar

    Save

19. [Treatment of type II diabetes using homologous intermediate-acting insulin combinations. Comparison of the effectiveness of 5 commonly used preparations].

    E. Haupt, F. Hoppe, R. Rudolf, E. Bamberg

    2008Deutsche Medizinische Wochenschrift2 citations

    Semantic Scholar

    Save

20. Effectiveness and Tolerability of the α-Glucosidase Inhibitor Acarbose in NIDDM Patients with Elevated Liver Enzyme Activity

    E. Haupt, I. Hillebrand, H. Pfeffer

    19882 citations

    Semantic Scholar

    Save

21. [Pharmacodynamics and pharmacokinetics of 2 glibenclamide preparations in type 2 diabetes. Intraindividual double-blind comparison of Euglucon 5 (HB 419) and Euglucon N (HB 420)].

    E. Haupt, F. Putschky, M. Zoltobrocki, K. Schöffling

    1984Deutsche Medizinische Wochenschrift2 citations

    Semantic Scholar

    Save

22. [Pharmacologic study with glisoxepide and other blood sugar reducing sulfonamide derivatives in metabolically healthy subjects and diabetics].

    E. Haupt, J. Beyer, K. Schöffling

    1974Arzneimittel-Forschung2 citations

    Semantic Scholar

    Save

23. [Therapy of diabetes in adults using Glibornurid. Results and clinical studies].

    K. Schöffling, H. Mehnert, W. Ewald, E. Haupt +3 more

    1973Deutsche Medizinische Wochenschrift2 citations

    Semantic Scholar

    Save

24. [Clinical experiences in long-term therapy of adult diabetes using glibornuride (Ro 6-4563)].

    W. Ewald, H. Hartmann, E. Haupt, W. Kunkel +6 more

    1973Medizinische Klinik2 citations

    Semantic Scholar

    Save

25. [Oral glucose tolerance tests--with or without estimation of serum insulin? (author's transl)].

    E. Haupt, R. Petzoldt, S. Probst, K. Schöffling

    2008Deutsche Medizinische Wochenschrift1 citations

    Semantic Scholar

    Save

26. [Biosynthetic human insulin in comparison with conventional intermediary insulin from cattle].

    H. Etti, E. Bamberg, F. Enzmann, E. Haupt

    1983Die Medizinische Welt1 citations

    Semantic Scholar

    Save

27. [Biosynthetic human insulin. Comparison of the activity profile of human NPH-insulin and swine NPH-insulin in type I diabetics].

    H. Etti, E. Haupt

    1983MMW, Munchener medizinische Wochenschrift1 citations

    Semantic Scholar

    Save

28. [Attempted suicide using glibenclamide--also a contribution to the characterization of sulfonylurea effect].

    E. Haupt, R. Petzoldt, K. Schöffling

    1977Deutsche Medizinische Wochenschrift1 citations

    Semantic Scholar

    Save

29. [Cost-benefit analyses of the employment of assistant dieticians by medical practitioners. 1st report: Basic considerations, calculatory basis, analysis of a policlinical research study and preliminary assessment of an in-practice project (author's transl)].

    R. Petzoldt, E. Haupt, K. Schöffling

    1977Medizinische Klinik1 citations

    Semantic Scholar

    Save

30. [Value of biguanide in therapy of diabetes mellitus].

    E. Haupt, U. Panten

    1997Medizinische Klinik0 citations

    Semantic Scholar

    Save

31. [Clinical aspects of primary and secondary prevention of the metabolic syndrome and type II diabetes mellitus. Current status in Germany].

    E. Haupt

    1996Medizinische Klinik0 citations

    Semantic Scholar

    Save

32. [Insulin pump malfunctions with severe hypoglycemia during altitude changes].

    B. Regling, H. Hasche, E. Oertel, E. Haupt

    1990Deutsche Medizinische Wochenschrift0 citations

    Semantic Scholar

    Save

33. [Oral therapy of type II diabetes].

    E. Haupt, K. Schöffling

    1989Medizinische Klinik0 citations

    Semantic Scholar

    Save

34. [Are we prescribing too many sulfonylurea drugs?].

    E. Haupt, R. Landgraf

    1987Deutsche Medizinische Wochenschrift0 citations

    Semantic Scholar

    Save

35. [Efficacy of an educational program for type I and type II diabetic patients. Results within the scope of an inpatient stay].

    E. Haupt, F. Hoppe, E. Bamberg

    1986Fortschritte der Medizin0 citations

    Semantic Scholar

    Save

36. Humaninsulin und Insulinallergie

    H. Etti, E. Haupt

    19830 citations

    Semantic Scholar

    Save

37. [Changes in blood glucose, insulin, cortisol, growth hormone and glucagon induced by sulfonylures].

    E. Haupt, R. Petzoldt, J. Treiber, K. Schöffling

    1982Die Medizinische Welt0 citations

    Semantic Scholar

    Save

38. [How reliable are ambulatory patient-monitored blood-sugar measurements? A multicentre trial].

    K. Schöffling, W. Bachmann, H. Drost, F. Gries +6 more

    1982Deutsche Medizinische Wochenschrift0 citations

    Semantic Scholar

    Save

39. [Clinical pharmacology of two new oral antidiabetics of the sulfonamide type (author's transl)].

    E. Haupt, K. Küllmer, K. Schöffling

    1977Klinische Wochenschrift0 citations

    Semantic Scholar

    Save

40. [Pathological reaction of the adenyl-cyclase-cAMP-system on the glucagon dosage in uremia].

    J. Vlachoyannis, T. Hartenstein-Pettla, C. Meyer, G. Meyer +3 more

    1976Verhandlungen der Deutschen Gesellschaft fur Innere Medizin0 citations

    Semantic Scholar

    Save

41. [Clinical experience with the blood sugar reducing sulfonamide derivative glisoxepide].

    R. Petzoldt, G. Riedesel, M. Ramrath, V. Grabs +5 more

    1974Arzneimittel-Forschung0 citations

    Semantic Scholar

    Save

42. Investigations on the Antilipolytic Activity of Sulfonylureas in Man with Indications on Limit Dosages Concerning their Insulin-Secreting Properties

    C. Rosak, E. Haupt, J. Beyer, K. Schöffling

    1974Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme0 citations

    Semantic Scholar

    Save

43. [Effect of a combined antibacterial therapy using sulfamethoxazole and trimethoprim on the metabolism of diabetics].

    U. Schwedes, E. Haupt, K. M. Bartelt, J. Beyer +1 more

    1974Die Medizinische Welt0 citations

    Semantic Scholar

    Save

44. Eighth annual meeting of the European Association for the Study of Diabetes

    K. Alberti, J. Darley, P. Emerson, T. Hockaday +496 more

    1973Diabetologia0 citations

    Semantic Scholar

    Save

45. [Insulin secretion following combined administration of glucose and different sulfonylurea compounds in equipotential doses in metabolically healthy persons].

    J. Happ, J. Beyer, E. Jungmann, U. Scherer +2 more

    1973Verhandlungen der Deutschen Gesellschaft fur Innere Medizin0 citations

    Semantic Scholar

    Save

46. [Longtime effect of blood sugar decreasing sulfonamides on glucose tolerance and insulin secretion in adult diabetic patients].

    E. Haupt, U. Cordes, R. Petzoldt, J. Beyer +1 more

    1973Verhandlungen der Deutschen Gesellschaft fur Innere Medizin0 citations

    Semantic Scholar

    Save

47. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].

    J. Beyer, E. Haupt, U. Cordes, G. Sell +1 more

    1973Arzneimittel-Forschung0 citations

    Semantic Scholar

    Save

48. [Recent findings in the use of 1st and 2nd generation hypoglycemic sulfonamides].

    K. Schöffling, E. Haupt, W. Köberich, J. Beyer

    1973Klinische Wochenschrift0 citations

    Semantic Scholar

    Save

49. [Betacytotropic and antilipolytic effect of critical doses of tolbutamide and glibenclamide].

    C. Rosak, E. Haupt, K. M. Bartelt, J. Beyer +1 more

    1972Verhandlungen der Deutschen Gesellschaft fur Innere Medizin0 citations

    Semantic Scholar

    Save

50. [Insulin liberation by blood sugar decreasing sulfonamides and by glucose in adult diabetic patients].

    E. Haupt, W. Köberich, C. Rosak, J. Beyer +1 more

    1972Arzneimittel-Forschung0 citations

    Semantic Scholar

    Save